MRI-guided adaptive radiotherapy in locally advanced cervical cancer from a Nordic perspective
Top Cited Papers
Open Access
- 21 August 2013
- journal article
- research article
- Published by Informa UK Limited in Acta Oncologica
- Vol. 52 (7), 1510-1519
- https://doi.org/10.3109/0284186x.2013.818253
Abstract
Background. The first Nordic protocol for three-dimensional (3D) planned radiotherapy in locally advanced cervical cancer was the prospective NOCECA study (1994–2000). NOCECA consisted of computed tomography (CT)-based 3D conformal external beam radiotherapy (EBRT) with a simultaneous integrated boost (SIB) to the primary tumour combined with brachytherapy (BT) based on x-ray imaging. In NOCECA the planning aim was to achieve 80 Gy at point A from EBRT and BT combined. However, the balance of dose between EBRT and BT was determined by tumour size at diagnosis with more EBRT dose given to point A and less by BT in more advanced stages. In 2005 image-guided adaptive brachytherapy (IGABT) based on magnetic resonance imaging (MRI) and optimisation of the BT dose distribution to the remaining tumour and cervix at time of BT (HR CTV) was introduced in Aarhus. EBRT remained like in NOCECA until 2008 when the SIB to the primary tumour was abandoned and IMRT was introduced as routine technique. In this study, we report outcome of our first five-year experience with IGABT using our NOCECA cohort as reference. Material and methods. The NOCECA cohort comprising 99 patients was compared with 140 consecutive patients treated by IGABT. Patients with para-aortic nodes were excluded in NOCECA but were present in 9% of the patients treated with IGABT. No patient in NOCECA received chemotherapy whereas concomitant cisplatin was given to 79% of the IGABT patients. Results. With IGABT actuarial local control was 91% at three years. When comparing NOCECA with IGABT overall survival was significantly improved from 63% to 79% (p = 0.005). In parallel, both moderate and severe late morbidity were reduced by about 50% (p = 0.02). Conclusion. Introduction of IGABT reduced morbidity and generated a very high rate of local control, which likely has improved survival by at least as much as concomitant chemotherapy.Keywords
This publication has 49 references indexed in Scilit:
- Clinical feasibility of combined intracavitary/interstitial brachytherapy in locally advanced cervical cancer employing MRI with a tandem/ring applicator in situ and virtual preplanning of the interstitial componentRadiotherapy and Oncology, 2013
- International Brachytherapy Practice Patterns: A Survey of the Gynecologic Cancer Intergroup (GCIG)International Journal of Radiation Oncology*Biology*Physics, 2012
- Translating Response During Therapy into Ultimate Treatment Outcome: A Personalized 4-Dimensional MRI Tumor Volumetric Regression Approach in Cervical CancerInternational Journal of Radiation Oncology*Biology*Physics, 2010
- MRI Assessment of Cervical Cancer for Adaptive RadiotherapyStrahlentherapie und Onkologie, 2009
- Survey of the use of the ICRU 38 in recording and reporting cervical cancer brachytherapyRadiotherapy and Oncology, 2001
- Randomized Comparison of Fluorouracil Plus Cisplatin Versus Hydroxyurea as an Adjunct to Radiation Therapy in Stage IIB-IVA Carcinoma of the Cervix With Negative Para-Aortic Lymph Nodes: A Gynecologic Oncology Group and Southwest Oncology Group StudyJournal of Clinical Oncology, 1999
- Concurrent Cisplatin-Based Radiotherapy and Chemotherapy for Locally Advanced Cervical CancerNew England Journal of Medicine, 1999
- Tumor Size, Irradiation Dose, and Long-Term Outcome of Carcinoma of Uterine CervixInternational Journal of Radiation Oncology*Biology*Physics, 1998
- Continuous or Split-Course Combined External and Intracavitary Radiotherapy of Locally Advanced Carcinoma of the Uterine CervixActa Oncologica, 1994
- Radiotherapy alone in carcinoma of the intact uterine cervix according to G. H. Fletcher guidelines: A french cooperative study of 1383 casesInternational Journal of Radiation Oncology*Biology*Physics, 1988